Georges Gaudriault
Director Técnico/Científico/I+D en DEINOVE .
Cargos activos de Georges Gaudriault
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| DEINOVE | Director Técnico/Científico/I+D | 23/05/2017 | - |
Historial de carrera de Georges Gaudriault
Antiguos cargos conocidos de Georges Gaudriault.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Obe Therapy Biotechnology SAS
 Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Director Técnico/Científico/I+D | - | - |
Obetherapy
 Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Director Técnico/Científico/I+D | - | - |
| MEDINCELL S.A. | Director Técnico/Científico/I+D | - | - |
Formación de Georges Gaudriault.
| University of Nice Sophia Antipolis | Doctorate Degree |
Estadísticas
Internacional
| Francia | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Obe Therapy Biotechnology SAS
Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Health Services |
Obetherapy
Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Health Technology |
- Bolsa de valores
- Insiders
- Georges Gaudriault
- Experiencia